Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis.

Van Der Meeren O, Hatherill M, Nduba V, Wilkinson RJ, Muyoyeta M, Van Brakel E, Ayles HM, Henostroza G, Thienemann F, Scriba TJ, Diacon A, Blatner GL, Demoitié MA, Tameris M, Malahleha M, Innes JC, Hellström E, Martinson N, Singh T, Akite EJ, Khatoon Azam A, Bollaerts A, Ginsberg AM, Evans TG, Gillard P, Tait DR.

N Engl J Med. 2018 Oct 25;379(17):1621-1634. doi: 10.1056/NEJMoa1803484. Epub 2018 Sep 25.

2.

Behaviour of estrogenic endocrine-disrupting chemicals in permeable carbonate sands.

Shepherd BO, Erler DV, Tait DR, van Zwieten L, Kimber S, Eyre BD.

Environ Sci Pollut Res Int. 2015 Aug;22(15):11340-8. doi: 10.1007/s11356-015-4238-8. Epub 2015 Mar 26.

PMID:
25804658
3.

Normality of colour vision in a compound heterozygous female carrying protan and deutan defects.

Tait DM, Carroll J.

Clin Exp Optom. 2009 Jul;92(4):356-61. doi: 10.1111/j.1444-0938.2009.00359.x. Epub 2009 Mar 17.

4.

Topography of the long- to middle-wavelength sensitive cone ratio in the human retina assessed with a wide-field color multifocal electroretinogram.

Kuchenbecker JA, Sahay M, Tait DM, Neitz M, Neitz J.

Vis Neurosci. 2008 May-Jun;25(3):301-6. doi: 10.1017/S0952523808080474.

5.
6.

A quantitative treatment planning study evaluating the potential of dose escalation in conformal radiotherapy of the oesophagus.

Bedford JL, Viviers L, Guzel Z, Childs PJ, Webb S, Tait DM.

Radiother Oncol. 2000 Nov;57(2):183-93.

PMID:
11054522
7.

Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial.

Powles R, Mehta J, Kulkarni S, Treleaven J, Millar B, Marsden J, Shepherd V, Rowland A, Sirohi B, Tait D, Horton C, Long S, Singhal S.

Lancet. 2000 Apr 8;355(9211):1231-7.

PMID:
10770306
8.

Ovarian cancer BRCA1 gene therapy: Phase I and II trial differences in immune response and vector stability.

Tait DL, Obermiller PS, Hatmaker AR, Redlin-Frazier S, Holt JT.

Clin Cancer Res. 1999 Jul;5(7):1708-14.

9.

Recombinant tissue plasminogen activator (rtPA) for the treatment of hepatic veno-occlusive disease (VOD).

Kulkarni S, Rodriguez M, Lafuente A, Mateos P, Mehta J, Singhal S, Saso R, Tait D, Treleaven JG, Powles RL.

Bone Marrow Transplant. 1999 Apr;23(8):803-7.

10.

Renal dysfunction following autologous bone marrow transplantation in adult patients with acute leukemia.

Glynne P, Powles R, Steele J, Singhal S, Treleaven J, Tait D, Mehta J.

Acta Oncol. 1996;35(6):709-12.

PMID:
8938218
11.

High dose melphalan and total body irradiation with autologous marrow rescue in childhood acute lymphoblastic leukaemia after relapse.

Schroeder H, Pinkerton CR, Powles RL, Meller ST, Tait D, Milan S, McElwain TJ.

Bone Marrow Transplant. 1991 Jan;7(1):11-5.

PMID:
2043872
12.

Cytology of rheumatoid synovial cells in culture. III. Significance of isolates of epithelial cell lines.

Mackay JM, Norval M, Robinson A, Tait D, Hart H, Marmion BP, Muir A, Neill WA.

Ann Rheum Dis. 1974 Sep;33(5):453-60. No abstract available.

Supplemental Content

Loading ...
Support Center